Ligand-Based Approaches to In Silico Pharmacology

Methods in Molecular Biology

Volumn 672, Issue , 2011, Pages 489-502

  Vidal, David ^a   Garcia Serna, Ricard ^a   Mestres, Jordi ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Drug repurposing; Polypharmacology; Structure activity relationships; Target profiling; Topological descriptors

Indexed keywords

LIGAND;

ARTICLE; COMPUTER SIMULATION; DRUG DEVELOPMENT; DRUG INTERACTION; METHODOLOGY; PHARMACOKINETICS; PHARMACOLOGY;

COMPUTER SIMULATION; DRUG DISCOVERY; DRUG INTERACTIONS; LIGANDS; PHARMACOKINETICS; PHARMACOLOGY;

MLCS; MLOWN;

EID: 79952115164     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-839-3_19     Document Type: Chapter

References (25)

1. Ekins, S., Mestres, J., and Testa, B. (2008) In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 152, 9–20.
2. Ekins, S., Mestres, J., and Testa, B. (2008) In silico pharmacology for drug discovery: applications to targets and beyond. Br. J. Pharmacol. 152, 21–37.
3. Hansch, C. and Fujita, T. (1964) Rho-sigma-pi analysis: a method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 86, 1616–1626.
4. Hansch, C., Hoekman, D., Leo, A., Weininger, D., and Selassie, C. D. (2002) Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. Chem. Rev. 102, 783–812.
5. Kurup, A. (2003) C-QSAR: a database of 18,000 QSARs and associated biological and physical data. J. Comput. Aided Mol. Des. 17, 187–196.
6. Lahana, R. (1999) How many leads from HTS? Drug Discov. Today 4, 447–448.
7. Bajorath, J. (2002) Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov. 1, 882–894.
8. Willett, P. (2003) Similarity-based approaches to virtual screening. Biochem. Soc. Trans. 31, 603–606.
9. Lengauer, T., Lemmen, C., Rarey, M., and Zimmermann, M. (2004) Novel technologies for virtual screening. Drug Discov. Today 9, 27–34.
10. Bleicher, K. H., Böhm, H.-J., M€uller, K., and Alanine, A. I. (2003) Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2, 369–378.
11. Shoichet, B. K. (2004) Virtual screening of chemical libraries. Nature 432, 862–865.
12. Mestres, J. (2004) Computational chemogenomic approaches to systematic knowledge-based drug discovery. Curr. Top. Drug Discov. Dev. 7, 304–313.
13. Savchuk, N. P., Balakin, K. V., and Tkachenko, S. E. (2004) Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr. Opin. Chem. Biol. 8, 412–417.
14. Bredel, M. and Jacoby, E. (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genetics 5, 262–275.
15. Bajorath, J. (2008) Computational analysis of ligand relationships within target families. Curr. Opin. Chem. Biol. 12, 352–358.
16. Karelson, M. (2000) Molecular descriptors in QSAR/QSPR. Wiley-VCH: New York.
17. Todeschini, R. and Consonni, V. (2000) Handbook of molecular descriptors. Wiley-VCH: New York.
18. Walters, W. P. and Goldman, B. B. (2005) Feature selection in quantitative structure-activity relationships. Curr. Opin. Drug Discov. Devel. 8, 329–333.
19. Willett, P. (2006) Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046–1053.
20. Mestres, J., Gregori-Puigjané, E., Valverde, S., and Solé, R. V. (2009) The topology of drug-target interaction networks: implicit dependence on drug properties and protein families. Mol. Biosyst. 5, 1051–1057.
21. Gregori-Puigjané, E. and Mestres, J. (2006) SHED: Shannon entropy descriptors from topological feature distributions. J. Chem. Inf. Model. 46, 1615–1622.
22. Gregori-Puigjané, E. and Mestres, J. (2008) A ligand-based approach to mining the chemogenomic space of drugs. Comb. Chem. High Throughput Screen. 11, 669–676.
23. Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., and Shoichet, B. K. (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197–206.
24. Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., Whaley, R., Glennon, R. A., Hert, J., Thomas, K. L. H., Edwards, D. D., Shoichet, B. K., and Roth, B. L. (2009) Predicting new molecular targets for known drugs. Nature 462, 175–182.
25. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., and Bork, P. (2008) Drug target identification using side-effect similarity. Science 321, 263–266.